Denosumab for osteoporosis
Metadata[+] Show full item record
Denosumab (Prolia®) provides an alternative treatment for patients with osteoporosis that progresses despite bisphosphonate therapy, and for patients who cannot tolerate bisphosphonate therapy. Denosumab appears to be cost-effective compared with bisphosphonate therapy.
Evidence Based Practice 14(1): 01-02.